Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder.
Ann Clin Psychiatry. 2009 Jan-Mar;21(1):26-37.
Ann Clin Psychiatry. 2009.
PMID: 19239830
Clinical Trial.